Henry Wolfe

Henry Wolfe has extensive experience in the pharmaceutical industry. Henry currently holds the position of Senior Vice President, Biologics CMC at Centessa Pharmaceuticals since November 2022. Prior to this, they worked as the Vice President, Biologics Research & Development at Endo Pharmaceuticals from January 2019 to November 2022. Henry also served as the Senior Vice President Pharmaceutical Development at Antares Pharma Inc. from January 2017 to December 2018. Previously, they held the position of Vice President, Biologics at SUN PHARMA from February 2010 to December 2016. Henry has also worked as the Vice President, Generics R&D at URL Pharma, Inc. and Chief Scientific Officer at CombiMab, Executive Vice President & Chief Scientific Officer at Genaera Corporation, and Vice President, R&D at Targeted Diagnostics & Therapeutics, Inc. Additionally, Henry Wolfe has experience as an Associate Director at GE Healthcare and as a Group Leader at Sterling Winthrop.

Henry Wolfe earned a BA in Biology from Towson University in 1981. Henry later pursued a MS degree in Biochemistry & Nutrition from Virginia Tech, which they completed in 1983. From 1997 to 2006, Henry attended Jefferson Health, where they obtained a PhD in Structural Biology and Molecular Pharmacology.